New Key Statistics Module, Z-Score and F-Score
OTCPK:CLVLF Key Ratios
Market Cap $ M | 379.76 |
Enterprise Value $ M | 265.51 |
P/E(ttm) | 17.35 |
PE Ratio without NRI | 17.35 |
Forward PE Ratio | 17.98 |
Price/Book | 2.99 |
Price/Sales | 6.99 |
Price/Free Cash Flow | 19.69 |
Price/Owner Earnings | 17.42 |
Payout Ratio % | 0.07 |
Revenue (TTM) $ M | 58.00 |
EPS (TTM) $ | 0.47 |
Beneish M-Score | -2.25 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 31.30 |
y-y EBITDA Growth Rate % | 15.20 |
EV-to-EBIT | 7.68 |
EV-to-EBITDA | 7.52 |
PEG | 0.55 |
Shares Outstanding M | 50.06 |
Net Margin (%) | 40.41 |
Operating Margin % | 54.44 |
Pre-tax Margin (%) | 57.47 |
Quick Ratio | 8.39 |
Current Ratio | 8.81 |
ROA % (ttm) | 16.80 |
ROE % (ttm) | 19.57 |
ROIC % (ttm) | 98.82 |
Dividend Yield % | 0.40 |
Altman Z-Score | 15.31 |
CLVLF Number of Guru Trades
CLVLF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLVLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLVLF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Clinuvel Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:CLVLF
Total 0- 1